TGF-β / Smad Signaling
TGF-β / Smad Signaling(TGF-β / Smad 信号转导)
Transforming growth factor-beta (TGF-beta) is a multifunctional cytokine that regulates proliferation, migration, differentiation, and survival of many different cell types. Deletion or mutation of different members of the TGF-β family have been shown to cause vascular remodeling defect and absence of mural cell formation, leading to embryonic lethality or severe vascular disorders. TGF-β induces smooth muscle differentiation via Notch or SMAD2 and SMAD3 signaling in ES cells or in a neural crest stem cell line. TGF-β binds to TGF-βRI and to induce phosphorylation of SMAD2/3, thereby inhibiting proliferation, tube formation, and migration of endothelial cells (ECs).
TGF-β is a pluripotent cytokine with dual tumour-suppressive and tumour-promoting effects. TGF-β induces the epithelial-to-mesenchymal transition (EMT) leading to increased cell plasticity at the onset of cancer cell invasion and metastasis.
TGF-β / Smad Signaling 相关产品(360)
- GC32728LSKL, Inhibitor of Thrombospondin TSP-1CAS: 283609-79-0纯度: >98.00% / >99.50%
LSKL, Inhibitor of Thrombospondin TSP-1是一种来源于潜伏相关蛋白(LAP)-TGFβ的四肽,可竞争性结合抑制TGF-β1。
- GC33310Rho-Kinase-IN-1CAS: 1035094-83-7纯度: >99.50%
Rho-Kinase-IN-1是一个rho激酶抑制剂,来自专利US20090325960A1,化合物1.008。
- GC33368BCR-ABL-IN-2CAS: 897369-18-5
BCR-ABL-IN-2是BCR-ABL1激酶的抑制剂,其对ABL1native和ABL1T315I的IC50值分别为57nM,773nM。
- GC33901Pentanoic acidCAS: 109-52-4纯度: >99.00%
Pentanoicacid是一种短链脂肪酸,是细菌代谢产物,与过敏性皮肤病有关系。Pentanoicacid能够激活ROCK信号通路。
- GC35651CenisertibCAS: 871357-89-0纯度: >99.50%
Cenisertib (AS-703569) 是一种多激酶抑制剂,可抑制 Aurora-kinase-A/B,ABL1,AKT,STAT5, FLT3 的活性。 Cenisertib 通过抑制肿瘤肥大细胞 (MC) 中几种不同分子靶标的活性抑制其生长。 Cenisertib 抑制异种移植模型中胰腺癌,乳腺癌,结肠癌,卵巢癌和肺癌以及白血病的肿瘤生长。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC32714 | Mitoxantrone (mitozantrone) | 65271-80-9 | >98.00% | |
米托蒽醌Mitoxantrone是一种抗肿瘤的蒽醌衍生物。 | ||||
| GC32728 | LSKL, Inhibitor of Thrombospondin TSP-1 | 283609-79-0 | >98.00% / >99.50% | |
LSKL, Inhibitor of Thrombospondin TSP-1是一种来源于潜伏相关蛋白(LAP)-TGFβ的四肽,可竞争性结合抑制TGF-β1。 | ||||
| GC32788 | SJ000291942 | 425613-09-8 | >98.00% | |
A BMP signaling activator | ||||
| GC32811 | LXS196 | 1874276-76-2 | >99.50% | |
A PKC inhibitor | ||||
| GC32840 | R-268712 | 879487-87-3 | >99.50% | |
R-268712 is a potent and selective inhibitor of ALK5 with an IC50 of 2.5 nM. | ||||
| GC32867 | Flumatinib (HHGV678) | 895519-90-1 | >98.00% | |
A Bcr-Abl inhibitor | ||||
| GC32868 | BDP5290 | 1817698-21-7 | >98.50% | |
BDP5290对MRCKβ、ROCK1、ROCK2的IC50值分别为17nM、230nM、123nM和100nM,是ROCK和MRCK的有效抑制剂。 | ||||
| GC32870 | Ingenol ((-)-Ingenol) | 30220-46-3 | >98.00% | |
A PKC activator | ||||
| GC32914 | EMT inhibitor-1 | 1638526-21-2 | >99.00% | |
EMTinhibitor-1是Hippo,TGF-β和Wnt信号通路的抑制剂,并拥有抗肿瘤活性。 | ||||
| GC33120 | ZINC00881524 | 557782-81-7 | >99.00% | |
A ROCK inhibitor | ||||
| GC33201 | GZD856 | 1257628-64-0 | - | |
GZD856是一种新型,有口服活性的PDGFRα/β抑制剂,IC50分别为68.6和136.6nM。具有抗肺癌活性。也是Bcr-AblT315I的抑制剂,对Bcr-Abl和T315I突变型的IC50分别为19.9和15.4 nM。 | ||||
| GC33310 | Rho-Kinase-IN-1 | 1035094-83-7 | >99.50% | |
Rho-Kinase-IN-1是一个rho激酶抑制剂,来自专利US20090325960A1,化合物1.008。 | ||||
| GC33343 | BCR-ABL-IN-1 | 188260-50-6 | - | |
BCR-ABL-IN-1是一种BCR-ABL酪氨酸激酶抑制剂,pIC50值为6.46,可能用于慢性髓细胞白血病的研究。 | ||||
| GC33351 | CZC-8004 (CZC-00008004) | 916603-07-1 | >99.50% | |
A tyrosine kinase inhibitor | ||||
| GC33368 | BCR-ABL-IN-2 | 897369-18-5 | - | |
BCR-ABL-IN-2是BCR-ABL1激酶的抑制剂,其对ABL1native和ABL1T315I的IC50值分别为57nM,773nM。 | ||||
| GC33901 | Pentanoic acid | 109-52-4 | >99.00% | |
Pentanoicacid是一种短链脂肪酸,是细菌代谢产物,与过敏性皮肤病有关系。Pentanoicacid能够激活ROCK信号通路。 | ||||
| GC34060 | Disitertide (P144) | 272105-42-7 | >98.00% | |
Disitertide (P144)是转化生长因子β1(TGF-β1)受体I型的特异性抑制剂。 | ||||
| GC34300 | AR-13324 analog mesylate | 2095432-73-6 | - | |
AR-13324类似物甲磺酸盐是AR-13324的类似物。 | ||||
| GC34493 | BIBF0775 | 334951-90-5 | >99.50% | |
BIBF-0775 is a selective inhibitor of transforming growth factor β Receptor I (TGFβRI,Alk5) with an IC50 of 34nM. | ||||
| GC35210 | A 83-01 sodium salt | 2828431-89-4 | >98.00% | |
A TGF-β type I receptor inhibitor | ||||
| GC35442 | Azaindole 1 | 867017-68-3 | >98.00% | |
A ROCK1 and ROCK2 inhibitor | ||||
| GC35462 | Bafetinib | 859212-16-1 | >99.50% | |
A Bcr-Abl inhibitor | ||||
| GC35530 | BJE6-106 | 1564249-38-2 | - | |
BJE6-106 (B106) 是一种有效的选择性 PKCδ 抑制剂,IC50 值为 0.05 μM,BJE6-106 (B106) 靶向 PKCδ 的选择性是 PKC 同工酶 PKCα 的 1000倍 (IC50=50 μM)。BJE6-106 (B106) 可以诱导 caspase 依耐性细胞凋亡 (apoptosis)。BJE6-106 (B106) 具有肿瘤特异性作用。 | ||||
| GC35651 | Cenisertib | 871357-89-0 | >99.50% | |
Cenisertib (AS-703569) 是一种多激酶抑制剂,可抑制 Aurora-kinase-A/B,ABL1,AKT,STAT5, FLT3 的活性。 Cenisertib 通过抑制肿瘤肥大细胞 (MC) 中几种不同分子靶标的活性抑制其生长。 Cenisertib 抑制异种移植模型中胰腺癌,乳腺癌,结肠癌,卵巢癌和肺癌以及白血病的肿瘤生长。 | ||||
